Πλοήγηση ανά Θέμα "patent ductus arteriosus"

Αποτελέσματα 1-2 από 2

Comparative safety and efficacy of paracetamol versus non-steroidal anti-inflammatory agents in neonates with patent ductus arteriosus: A systematic review and meta-analysis of randomized controlled trials

Katsaras D.N., Katsaras G.N., Chatziravdeli V.I., Papavasileiou G.N., Touloupaki M., Mitsiakos G., Doxani C., Stefanidis I., Dardiotis E. (2022)

Aim: Ibuprofen and indomethacin are the preferred drug treatment for patent ductus arteriosus (PDA) in preterm neonates. The comparative safety and efficacy of paracetamol as an alternative has not yet been well established. ...
Very preterm neonates receiving “aggressive” nutrition and early nCPAP had similar long-term respiratory outcomes as term neonates

Panagiotounakou P., Sokou R., Gounari E., Konstantinidi A., Antonogeorgos G., Grivea I.N., Daniil Z., Gourgouliannis K.I., Gounaris A. (2019)

Backround: The impact of the consistent implementation of “aggressive” nutrition by means of intensive early neonatal nutritional support up to 40–44 weeks postmenstrual age and the use of nasal continuous positive airway ...